{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:09Z","timestamp":1753891869363,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T00:00:00Z","timestamp":1613520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Idiopathic congenital chylothorax is a rare but serious disease. Advancement in perinatal care and the renovated treatment modalities have brought about significant improvement in patient outcome.<\/jats:p><jats:p><jats:bold>Objective:<\/jats:bold> To describe the clinical course of severe forms of idiopathic congenital chylothorax, focusing on the development of recent treatment modalities and their impacts.<\/jats:p><jats:p><jats:bold>Design:<\/jats:bold> A retrospective cohort by review of medical records in the NICU of a perinatal referral center in Taiwan. Study period was from January 2006 to June 2017. Neonates with the diagnosis of idiopathic congenital chylothorax with non-immune hydrops fetalis were enrolled. Clinical relevant including demographic data, perinatal interventions, post-natal course, and treatment outcome were described and analyzed.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Twenty-eight neonatal patients were included. The median gestational age at birth was 34 (range 27\u201336) weeks and median birth weight was 2,369 (range 1,430\u20133,608) g. Prenatal intervention was performed in 39.3% of the patients. Besides, 11 out of the 28 neonates developed tension pneumothorax in the first 24 h and 4 (36.4%) of them died. Sepsis was documented in two patients (7.1%). Overall survival rate was 71.4%. There were five patients enrolled during the last 2 years of the study period. EXIT with intubation was performed in two and octreotide was given to four of these most recent neonates, and all of them survived.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Recent advances in the management of these neonates, specifically EXIT with intubation and use of octreotide. Both of them improved patient survival in our cohort, but the evidence of impact has yet to be validated.<\/jats:p>","DOI":"10.3389\/fped.2021.633051","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T21:14:32Z","timestamp":1613769272000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Staged Management of Congenital Chylothorax With Hydrops Fetalis: An Insight Into EXIT Related Procedures"],"prefix":"10.3389","volume":"9","author":[{"given":"Hung-Lin","family":"Tai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tze Yee Diane","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Shine","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ming","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyin","family":"Lien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/RRN.S128703","article-title":"Congenital chylothorax: current perspectives and trends","volume":"7","author":"Krishnamurthy","year":"2017","journal-title":"Res Rep Neonatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1111\/j.1651-2227.2010.01884.x","article-title":"Congenital chylothorax: from foetal life to adolescence","volume":"99","author":"Caserio","year":"2010","journal-title":"Acta Paediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1164\/ajrccm.161.3.9904056","article-title":"Thoracic lymphangiomas, lymphangiectasis, lymphangiomatosis, and lymphatic dysplasia syndrome","volume":"161","author":"Faul","year":"2000","journal-title":"Am J Respir Crit Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"F169","DOI":"10.1136\/archdischild-2014-307274","article-title":"Group Erhebungseinheit fur seltene padiatrische Erkrankungen in Deutschland Study. Congenital chylothorax: a prospective nationwide epidemiological study in Germany","volume":"100","author":"Bialkowski","year":"2015","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.siny.2017.03.005","article-title":"Congenital chylothorax","volume":"22","author":"Attar","year":"2017","journal-title":"Semin Fetal Neonatal Med."},{"key":"B6","first-page":"91","article-title":"Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective study","volume":"45","author":"Bellini","year":"2012","journal-title":"Lymphology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1080\/08035250500477545","article-title":"Pleural effusions in the neonate","volume":"95","author":"Rocha","year":"2006","journal-title":"Acta Paediatr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000020863","article-title":"Primary fetal hydrothorax: a literature review and proposed antenatal clinical strategy","volume":"13","author":"Aubard","year":"1998","journal-title":"Fetal Diagn Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.1982.03330110056030","article-title":"Congenital bilateral chylothorax. Antepartum diagnosis and successful intrauterine surgical management","volume":"248","author":"Petres","year":"1982","journal-title":"JAMA."},{"key":"B10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1159\/000262270","article-title":"Fetal hydrothorax in the second trimester of pregnancy: successful intra-uterine treatment at 24 weeks gestation","volume":"1","author":"Roberts","year":"1986","journal-title":"Fetal Ther."},{"key":"B11","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/pd.1808","article-title":"Isolated fetal hydrothorax with hydrops: a systematic review of prenatal treatment options","volume":"27","author":"Deurloo","year":"2007","journal-title":"Prenat Diagn."},{"key":"B12","unstructured":"Insertion of Pleuro-amniotic Shunt for Fetal Pleural Effusion Interventional Procedures Guidance [IPG190]2006"},{"key":"B13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pedneo.2015.07.001","article-title":"Prenatal therapy improves the survival of premature infants with congenital chylothorax","volume":"57","author":"Lee","year":"2016","journal-title":"Pediatr Neonatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/jp.2017.150","article-title":"Prenatal factors associated with neonatal survival of infants with congenital chylothorax","volume":"38","author":"Dorsi","year":"2018","journal-title":"J Perinatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0022-3468(89)80509-3","article-title":"Primary fetal hydrothorax: natural history and management","volume":"24","author":"Longaker","year":"1989","journal-title":"J Pediatr Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2399\/prn.15.0231013","article-title":"Extrauterine intrapartum treatment procedure in the unilateral advanced fetal hydrothorax case","volume":"23","author":"Eraslan","year":"2015","journal-title":"Perinat J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0022-3468(97)90184-6","article-title":"Operating on placental support: the ex utero intrapartum treatment procedure","volume":"32","author":"Mychaliska","year":"1997","journal-title":"J Pediatr Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/00008480-200208000-00018","article-title":"The ex-utero intrapartum treatment","volume":"14","author":"MacKenzie","year":"2002","journal-title":"Curr Opin Pediatr."},{"key":"B19","doi-asserted-by":"publisher","first-page":"F58","DOI":"10.1136\/fn.86.1.F58","article-title":"Ex utero intrapartum treatment (EXIT) of severe fetal hydrothorax","volume":"86","author":"Prontera","year":"2002","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B20","doi-asserted-by":"publisher","first-page":"F327","DOI":"10.1136\/adc.2007.136820","article-title":"Early-onset pneumothorax indicates poor outcome in newborns with congenital idiopathic chylothorax","volume":"93","author":"Diomande","year":"2008","journal-title":"Arch Dis Child Fetal Neonatal Ed."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0012-3692(15)51155-0","article-title":"Pathophysiology of pneumothorax following ultrasound-guided thoracentesis","volume":"130","author":"Heidecker","year":"2006","journal-title":"Chest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1001\/jama.2014.5552","article-title":"Does this patient have an exudative pleural effusion? The Rational Clinical Examination systematic review","volume":"311","author":"Wilcox","year":"2014","journal-title":"JAMA."},{"key":"B23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0003-4975(98)00361-0","article-title":"Treatment of a persistent postoperative chylothorax with somatostatin","volume":"66","author":"Rimensberger","year":"1998","journal-title":"Ann Thorac Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1056\/NEJM199601253340408","article-title":"Octreotide","volume":"334","author":"Lamberts","year":"1996","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006388.pub2","article-title":"Octreotide for the treatment of chylothorax in neonates","author":"Das","year":"2010","journal-title":"Cochr Datab Syst Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s00134-006-0114-9","article-title":"Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review","volume":"32","author":"Roehr","year":"2006","journal-title":"Intensive Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e7594","DOI":"10.1097\/MD.0000000000007594","article-title":"Effects of somatostatin\/octreotide treatment in neonates with congenital chylothorax","volume":"96","author":"Yin","year":"2017","journal-title":"Medicine (Baltimore)."},{"key":"B28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/jpc.13889","article-title":"Octreotide for congenital and acquired chylothorax in newborns: a systematic review","volume":"54","author":"Bellini","year":"2018","journal-title":"J Paediatr Child Health."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.633051\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T21:14:36Z","timestamp":1613769276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.633051\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,17]]},"references-count":28,"alternative-id":["10.3389\/fped.2021.633051"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.633051","relation":{},"ISSN":["2296-2360"],"issn-type":[{"type":"electronic","value":"2296-2360"}],"subject":[],"published":{"date-parts":[[2021,2,17]]},"article-number":"633051"}}